Diabetes Mellitus Self-Monitoring of Blood Glucose
Conditions
Interventions
Patients with diabetes who received insulin therapy or injectable GLP-1 receptor agonist and are on SMBG within insurance coverage will be included.
This is a single-center, single-arm pilot study wit
Sponsors
Kumashiro Naoki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients with diabetes age 18 years or older 2) Patients receiving insulin therapy or injectable GLP-1 receptor agonist medication and have been on SMBG for at least 12 weeks with insurance coverage. 3) Patients using SMBG devices that do not have a mentor function and are not able to utilize the application in a mobile tool, or using SMBG devices with a mentor function and are not using the application in a mobile tool. 4) Own a personal smart phone. 5) Smartphone application is available. 6) HbA1c less than 10.0% at the time of eligibility determination 7) Patients who were obtained written consent.
Exclusion criteria
Exclusion criteria: 1) Diabetic ketoacidosis 2) History of severe hypoglycemia with coma or loss of consciousness 3) Severe infection or serious trauma 4) History of hospitalization within 12 weeks prior to consent 5) Proliferative diabetic retinopathy or maculopathy requiring immediate treatment 6) Patients with malignant tumors and collagen diseases in poor condition despite treatment 7) Women in pregnant or possible pregnant 8) Diagnosed or suspected dementia (the Dementia Assessment Sheet for Community-based Integrated Care System-8 items (DASC-8) score of 11 or more) 9) Patients who were deemed inappropriate for the participation by the principal investigater or investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in total score of DTR-QOL | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in the following No.1-5 from 0 to 24 weeks 1. HbA1c 2. Percentage of blood glucose 180 mg/dL 3. Nutrient and energy intake evaluated by the Brief-type self-administered Diet History Questionnaire (BDHQ) 4. Number of SMBG tests 5.Bodyweight Factors which affect the change in total score of DTR-QOL | — |
Contacts
Public ContactMaki Ikoma
Department of Diabetology and Endocrinology, Kanazawa Medical University
Outcome results
None listed